type here...
type here...
START FREE TRIAL

M&A

Technology & AIM&AHealthcareConsumer & RetailMiscellaneousEnergy

Rogers MLSE Acquisition Tests Sports Media Ambitions

M&A Ishan Majumdar -
Rogers Communications (NYSE:RCI) just moved closer to full control of one of Canada’s most valuable sports platforms. The company agreed to buy Kilmer Sports’...

Novartis’ $1.5 Billion Myricx Deal Tests Oncology Pipeline

M&A Ishan Majumdar -
Novartis (NYSE:NVS) has made another clear move toward oncology depth, agreeing to acquire U.K.-based Myricx Bio for up to $1.5 billion. The structure includes...
spot_imgspot_img

Kroger’s Giant Eagle Acquisition: Scale Or Risk?

M&A Ishan M. -
Kroger (NYSE:KR) is back in the grocery consolidation spotlight after confirming plans to acquire family-owned Giant Eagle for $1.65...

Datadog Acquisition Of Adaptive ML Could Boost AI Growth

M&A Ishan Majumdar -
Datadog (NASDAQ:DDOG) just made a notable AI move. On June 30, 2026, the company announced a deal to acquire...

Merck’s $11 BillionBio-Techne Deal Looks Strategic, But The Debt Trade-Off Is REAL

M&A Ishan Majumdar -
Merck KGaA (ETR:MRK) has made a bold early move under new CEO Kai Beckmann. The German drug, chemicals, and...

AbbVie’s $11 Billion Eczema Gamble Is Bigger Than Skin

M&A Ishan Majumdar -
AbbVie Inc. (NYSE:ABBV) may be close to buying Apogee Therapeutics for about $10.9 billion in cash. That is a...

Did Fox Pay $25 Billion For Roku’s Platform, Or Its Ad Data Edge?

M&A Ishan Majumdar -
Fox Corp (NASDAQ:FOXA) has made its biggest swing yet in streaming, agreeing to acquire Roku (NASDAQ:ROKU) in a cash-and-stock...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

M&A Ishan M. -
Incyte Corporation (NASDAQ:INCY) is back in the biotech deal spotlight. The company is reportedly nearing an agreement to acquire...
Load more

Rogers MLSE Acquisition Tests Sports Media Ambitions

M&A Ishan Majumdar -
Rogers Communications (NYSE:RCI) just moved closer to full control of one of Canada’s most valuable sports platforms. The company...

Novartis’ $1.5 Billion Myricx Deal Tests Oncology Pipeline

M&A Ishan Majumdar -
Novartis (NYSE:NVS) has made another clear move toward oncology depth, agreeing to acquire U.K.-based Myricx Bio for up to...

Kroger’s Giant Eagle Acquisition: Scale Or Risk?

M&A Ishan M. -
Kroger (NYSE:KR) is back in the grocery consolidation spotlight after confirming plans to acquire family-owned Giant Eagle for $1.65...

Datadog Acquisition Of Adaptive ML Could Boost AI Growth

M&A Ishan Majumdar -
Datadog (NASDAQ:DDOG) just made a notable AI move. On June 30, 2026, the company announced a deal to acquire...

Merck’s $11 BillionBio-Techne Deal Looks Strategic, But The Debt Trade-Off Is REAL

M&A Ishan Majumdar -
Merck KGaA (ETR:MRK) has made a bold early move under new CEO Kai Beckmann. The German drug, chemicals, and...

AbbVie’s $11 Billion Eczema Gamble Is Bigger Than Skin

M&A Ishan Majumdar -
AbbVie Inc. (NYSE:ABBV) may be close to buying Apogee Therapeutics for about $10.9 billion in cash. That is a...

Did Fox Pay $25 Billion For Roku’s Platform, Or Its Ad Data Edge?

M&A Ishan Majumdar -
Fox Corp (NASDAQ:FOXA) has made its biggest swing yet in streaming, agreeing to acquire Roku (NASDAQ:ROKU) in a cash-and-stock...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

M&A Ishan M. -
Incyte Corporation (NASDAQ:INCY) is back in the biotech deal spotlight. The company is reportedly nearing an agreement to acquire...

Sony Just Made Music IP Look Like A Bigger SHIFT Than Games

M&A Ishan M. -
Sony Group Corporation (NYSE:SONY) is leaning harder into the business of owning culture, not just distributing it. The latest...

Meta Doesn’t Want to Build the Metaverse. It Wants to Build Your Robot

M&A Ishan M. -
Meta Platforms (NASDAQ:META) just made the kind of acquisition that sounds small until you zoom out. The company acquired...

This Cybersecurity Stock Is DEFYING The Mythos Panic With Its Latest AI Acquisition!

M&A Ishan Majumdar -
Palo Alto Networks (NASDAQ:PANW) has found itself in a strange spot. The stock is still down more than 18%...

Everyone Thinks Eli Lilly Is A Weight-Loss Stock. That’s The Trap

M&A Ishan Majumdar -
Eli Lilly (NYSE:LLY) is having one of those rare market moments where everyone thinks they understand the story. Weight-loss...
Load more

Baptista Research is a financial research house focused on the U.S. markets. We cover the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms.

Company

Headlines

SpaceX Stock Outlook After Starship Abort

0
Okay, let's talk about SpaceX for a second, because...

Verizon Job Cuts Signal a Wider AI and Retail Reinvention

0
Verizon Communications (NYSE:VZ) is preparing to cut roughly 3,000...

Meta AI Layoffs Lawsuit and Discrimination Claims

0
Meta Platforms (NASDAQ:META) has spent years telling investors that...

Is Warren Buffett’s Alphabet Bet Genius Or Terrible Timing?

0
Alphabet (NASDAQ:GOOGL) has received the kind of endorsement that...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 Baptista Research. All rights reserved.